Professor David Silbersweig, Harvard Medical School, co-founder of AIWS.net and member of AIWS City Board of Leaders, will speak at this event, October 22-24, 2020
Neuropsychiatry is an exciting and rapidly growing field that promotes an improved understanding of the brain/mind relationship. It seeks to elucidate the brain circuitry involved in primary psychiatric disorders such as mood, anxiety, psychotic, and somatic symptom disorders, and in neurological disorders that present with cognitive, emotional, or behavioral problems. The ultimate goal of neuropsychiatry is to advance diagnostic and treatment options for patients suffering from these disorders. This course is designed to enhance participants’ knowledge of brain-behavior relationships and their skills for the diagnostic work-up and treatment of patients with neuropsychiatric disorders. Faculty will review cutting-edge, clinical research, evidence-based interventions and practical guidelines for the clinician. The course content will include the functional neuroanatomy of emotions, cognition, and behavior; the fundamentals of the neuropsychiatric exam and relevant ancillary tests; and neuropsychopharmacological and non-pharmacological interventions in neuropsychiatric disorders. We will discuss the neuropsychiatric aspects of traumatic brain injury, epilepsy, neurodegenerative disorders, stroke, multiple sclerosis, functional neurological disorders, Tourette Syndrome, addiction, and other disorders.
The event can be found here.
Gaston Baslet, M.D., Scott McGinnis, M.D., Juan Carlos Urizar, M.D., Laura Safar, M.D., Kirk Daffner, M.D., David Silbersweig, M.D.